We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Peerport Limited (trading as MultiISA) is targeting the multi-million-pound market and claims to offer a holistic approach to Individual Savings Account (ISA) management. The company asserts that traditional ISA managers don’t give users enough flexibility with their investment choices. Current ISA rules restrict investors to only one ISA of each type per tax year. This impedes the investors’ ability to build a diversified IFISA portfolio. Peerport argues that its portal offers investors the freedom to operate multiple accounts like Innovative Finance ISA (IFISA), Cash ISA, and Stocks & Shares ISA under a single ISA management platform. The company will use the investment to finalise the build-out of its end to end platform, fund its office space, manage marketing costs, oversee staffing costs, pay regulatory fees and supervise working capital.

Pitch Rated

88%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £6,033
Core Collective is a luxury boutique fitness destination with a pay as you go model and an immersive and dynamic atmosphere. They provide all the benefits of a personal training session in a small class for a fraction of the cost and offer 7 different classes available for all levels of fitness. 
days to go: Expired investment: £2,056,412
niix is a fitness app plugging the gap in the market for women approaching 40. Since its launch in 2018, the company has created a 4+ star rated app with more than 1800 paid subscriptions across 25 countries including the US, Canada, and Australia. It also has an online following of tens of thousands. The global fitness app market is growing fast set to be worth $2 billion by 2023 with a focus on weight loss and body aesthetics for millennial markets. niix sees a huge opportunity in this space to support women who have simply outgrown an approach that want the perfect body and be fit lifelong. With the investment, the company will scale up proven marketing channels to grow community and subscriber bases, making niix the no.1 digital fitness brand for women approaching 40+.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £153,441
33Fuel is a natural sports nutrition brand that aims to dominate sports nutrition with healthier and natural alternatives. Its products consist of ingredients like organic flaxseeds, Tibetan goji berries, organic walnuts, and raw coconuts, to name a few. The company has received over 10,000 orders and multiple 5-star customer reviews. It has 12,000 email subscribers and a podcast with more than 65,000 plays. The company wants to dominate the sports nutrition market that is forecast to reach almost £2 billion by 2024. 33Fuel has attracted superstar shareholders including 4x Ironman Triathlon World Champion Chrissie Wellington and customers such as Tour de France winner Sir Bradley Wiggins. The company has won 'Health Product of the Year' and 'Best Meal Replacement' and has featured in fitness and mainstream media such as The Telegraph, Independent, and Men's Fitness. It will use the investment for marketing to accelerate sales.

Pitch Rated

74%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £367,124
OnCare is a digital care management software that is digitising elderly care, creating a global care marketplace via the OpenTable model to care. OnCare provides care agencies with the power to plan, manage and enhance care delivery and staff communication. Their mission is to make care easier for everyone. OnCare is currently live with over 110 home-care agencies around the UK, and more than 1100 care workers. The company is planning to enter markets of Hong Kong, Canada and Israel. With the proceeds, the company will use this fund for people, office space, technology, software, hosting and marketing.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £96,040
The British Design Fund invests in and provides support for early stage UK product design and manufacturing companies. The Fund seeks out extraordinary entreprenuers with scalable products ready to accelerate growth and build long term businesses. 
days to go: Expired investment: £350,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph